Pavol Jozef Safarik University   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Košice Slovakia (1959)

Organization Overview

First Clinical Trial
2010
NCT01116089
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Martin Janičko | Pavol Joef Safárik University, Faculty of Medicine | Pavol Josef Šafarik University, Faculty of Medicine, 040 11 Košice, Slovakia | Pavol Jozef Safarik University | Pavol Jozef Safarik University, Faculty of Medicine | University Hospital of L. Pasteur, Pneumonology Department, Rastislavova 43, 041 90, Kosice, Slovakia

Active Ingredients

Drugs in Phase 3 Trials (1)

human transfer factor (1 trial)

Drugs in Phase 1 Trials (3)

chia seed (1 trial)

fish oil (Omegavan) (1 trial)

tobramycin (nebcin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 1)

Fibrosis (Phase 3)

Hepatic Insufficiency (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Failure (Phase 3)

Metabolic Diseases (Phase 1)

Metabolic Syndrome (Phase 1)

Obesity, Abdominal (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4